The Market's Most Wanted 2024
Nifedipine - Signed Print by Damien Hirst 2012 - MyArtBroker

Nifedipine
Signed Print

Damien Hirst

£5,000-£7,500

Value Indicator

$9,500-$14,500 Value Indicator

$8,500-$13,000 Value Indicator

¥45,000-¥70,000 Value Indicator

6,000-9,000 Value Indicator

$50,000-$70,000 Value Indicator

¥960,000-¥1,430,000 Value Indicator

$6,500-$9,500 Value Indicator

37% AAGR

AAGR (5 years) This estimate blends recent public auction records with our own private sale data and network demand.

There aren't enough data points on this work for a comprehensive result. Please speak to a specialist by making an enquiry.

Medium: Woodcut

Edition size: 55

Year: 2012

Size: H 15cm x W 15cm

Signed: Yes

Format: Signed Print

MyPortfolio

Your collection tracked in real time.

Build your portfolio, manage valuations, view return against your collection and watch works you're looking for.

Track auction value trend

Damien Hirst's Nifedipine (signed) from 2012 is a rare woodcut artwork with an estimated value between £5,000 and £7,500. This artwork has an auction history of one sale on 13th December 2017. There have been no sales in the last 12 months and the hammer price over the last five years is not available. The edition size of this piece is limited to 55.

Unlock up-to-the-minute market data on Damien Hirst's Nifedipine, login or create a free account today

Auction Results

Auction DateAuction HouseArtwork
Hammer Price
Return to Seller
Buyer Paid
December 2017Christie's New York - United StatesNifedipine - Signed Print

Meaning & Analysis

More from the collection

Discover live market data against your collection

The only dedicated prints portfolio management system in the world. Add your collection to track value in real time.

Track demand on our trading floor

Track live demand in works from our artist's portfolios and view access to the works you're looking for.

What to
Invest in Now

Data-driven market commentary on what's driving growth, supply & demand in the Prints and Multiples market.